Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Mona Rafik"'
Autor:
Paul Henriot, Wagida A. Anwar, Maha El Gaafary, Samia Abdo, Mona Rafik, Wafaa M. Hussein, Dalia Sos, Isis Magdy, Kévin Jean, Laura Temime
Publikováno v:
PLOS Global Public Health, Vol 4, Iss 2 (2024)
Externí odkaz:
https://doaj.org/article/81260a5dbfb0445c95beadf5fed1ac6e
Autor:
Wagida A Anwar, Maha El Gaafary, Samia A Girgis, Mona Rafik, Wafaa M Hussein, Dalia Sos, Isis M Mossad, Arnaud Fontanet, Laura Temime
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246836 (2021)
BackgroundHospitals are suspected of playing a key role in HCV epidemic dynamics in Egypt. This work aimed at assessing HCV prevalence and associated risk factors in patients and health-care workers (HCWs) of Ain Shams University (ASU) hospitals in C
Externí odkaz:
https://doaj.org/article/a6eb9bb8d5784cf6affba7f855721602
Autor:
Aline Munier, Diaa Marzouk, Florence Abravanel, Mai El-Daly, Sylvia Taylor, Rasha Mamdouh, Waleed Salah Eldin, Hanan Ezz El-Arab, Dalia Gaber Sos, Mohamed Momen, Omar Okasha, Lenaig Le Fouler, Mostafa El-Hosini, Jacques Izopet, Mona Rafik, Matthew Albert, Mohamed Abdel-Hamid, Mostafa Kamal Mohamed, Elisabeth Delarocque-Astagneau, Arnaud Fontanet
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e57835 (2013)
BackgroundsWith 10% of the general population aged 15-59 years chronically infected with hepatitis C virus (HCV), Egypt is the country with the highest HCV prevalence worldwide. Healthcare workers (HCWs) are therefore at particularly high risk of HCV
Externí odkaz:
https://doaj.org/article/21daf44d26dc48ad88d38084e2899d88
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 11, Iss 3, Pp 134-134 (2000)
Externí odkaz:
https://doaj.org/article/f1468657c64b419294e0feb0e2e218f9
Autor:
Paul Henriot, Wagida Anwar, Maha El Gaafary, Samia Abdo, Mona Rafik, Wafaa Hussein, Dalia Sos, Isis Magdy, Kevin Jean, Laura Temime
When compliance with infection control recommendations is non-optimal, hospitals may play an important role in hepatitis C (HCV) transmission. However, few studies have analysed HCV acquisition risk based on detailed empirical data in order to identi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ed11ee54220e510b1f686af747732cef
https://doi.org/10.1101/2022.07.22.22277938
https://doi.org/10.1101/2022.07.22.22277938
Publikováno v:
Microbiology and Immunology. 65:76-84
To examine the cross-talk between NK cells and DCs in hepatitis C virus (HCV) infection, we isolated monocytes and NK cells from 20 chronic HCV patients and 20 healthy controls. Monocytes were used to generate immature DCs which were pulsed with HCV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73991f3ec574e21590dbdd6eff399fc2
https://doi.org/10.1111/1348-0421.12858
https://doi.org/10.1111/1348-0421.12858
Publikováno v:
The Egyptian Journal of Hospital Medicine. 66:123-126
Background: The global prevalence of chronic hepatitis C is estimated at 2.8%. There is markedly higher prevalence in the Middle East about 14.7% in Egypt. Dendritic cells (DCs) are one of the major Antigen presenting cells in the body. They bridge i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::31d8b66c597f661494827b2cd05278da
https://doi.org/10.12816/0034642
https://doi.org/10.12816/0034642
Autor:
Mostafa K. Mohamed, M. El Houssinie, M. Abdel Hamid, Elisabeth Delarocque-Astagneau, Bassim H, Omar Okasha, Aline Munier, Mona Rafik, Arnaud Fontanet
Publikováno v:
Eastern Mediterranean Health Journal. 21:199-212
The objectives of this study were to document the background prevalence and incidence of HCV infection among HCWs in Ain Shams University Hospitals in Cairo and analyse the risk factors for HCV infection. A cross-sectional survey was conducted in 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53222f1de5506ace0e639754a77931a0
https://doi.org/10.26719/2015.21.3.213
https://doi.org/10.26719/2015.21.3.213
Autor:
Amal A. Abbas, Charlotte Soneson, Armanda Casrouge, Mostafa K. Mohamed, Magnus Fontes, Mohamed Abdel-Hamid, Mai El-Daly, Noha Sharaf Eldin, Darragh Duffy, Melissa E. Laird, Arnaud Fontanet, Jérémie Decalf, Matthew L. Albert, Rasha Mamdouh, Mona Rafik, Lénaig Le Fouler
Publikováno v:
Hepatology. 59:1273-1282
Viral hepatitis is the leading cause of liver disease worldwide and can be caused by several agents, including hepatitis A (HAV), B (HBV), and C (HCV) virus. We employed multiplexed protein immune assays to identify biomarker signatures of viral hepa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4087cada0d4056a22388db6e993ceebf
https://doi.org/10.1002/hep.26901
https://doi.org/10.1002/hep.26901
Autor:
Loutfy, Mona Rafik1,2 mona.loutfy@wchospital.ca, Walmsley, Sharon Lynn2,3, Klein, Marina Barbara4, Janet Raboud3,5, Alice Lin-in Tseng2,3, Blitz, Sandra Lauren3, Neora Pick6,7, Brian Conway8, Angel, Jonathan Benjamin9,10, Rachlis, Anita Rochelle2,11, Gough, Kevin2,12, Cohen, Jeff13, Haase, David14,15, Burdge, David6,16, Smaill, Fiona Mary17, de Pokomandy, Alexandra4,18, Loemba, Hugues9,19, Trottier, Sylvie20, la Porte, Charles Jean9,10
Publikováno v:
BMC Infectious Diseases. 2013, Vol. 13 Issue 1, p1-10. 10p. 5 Charts, 1 Graph.